Talking Medicines

Talking Medicines

Private
GlasgowHealthcare & Life Scienceshttps://talkingmedicines.com

Last Round

Convertible Debt

Jan 31, 2024

Est. Valuation

$10.15M

Total Funding Raised

$4.25M

Momentum Score

25 /100

Company Overview

Talking Medicines is a healthtech company that provides a healthcare technology tool designed to capture, curate, and structure the voice of the patient on launched medicines.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Healthcare Analytics, Marketing, NLP & Conversational AI, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS, Data as a Service

AI Layer

Application

Keywords

healthcare intelligenceAI for pharmapatient experience insightsreal-world evidenceRWEreal-world dataRWDpharma marketing intelligencesocial media listeningpatient sentiment analysisHCP sentiment analysislife sciences AIlarge language modelhealthcare analyticsDrug-GPT

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Talking Medicines Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Talking Medicines Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Convertible DebtJan 31, 2024
SeedFeb 1, 2022
SeedNov 4, 2020
SeedAug 28, 2017
GrantAug 28, 2017

Key People

Founding team and executive leadership

Jo Halliday

Chief Executive Officer, Founder

Founding Team

Talking Medicines Investors

Notable investors and investment history

InvestorRounds
Tern PLCSeed, Convertible Debt
SIS VenturesSeed, Convertible Debt

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 8, 2026

    Included in Top 1,000 UK AI Companies list.

Talking Medicines Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Talking Medicines Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Talking Medicines's valuation, stock price, and market status.

Firmographic Details

HeadquartersGlasgow
Employee Range31
Year Founded2013
Last FundingJan 31, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.